Sfoglia per Rivista HAEMATOLOGICA
1,25-DIHYDROXYVITAMIN-D3 IN THE TREATMENT OF IDIOPATHIC THROMBOCYTHEMIA AND MYELOFIBROSIS
1990 P. FOA, A. MAIOLO, M. CORTELLARO, S. ORTOLANI, E. POGLIANI, G. DELILIERS, A. IURLO, L. ZOCCHI, A. GUALDONI, E. POLLI
10-year results with moppebvcad chemotherapy nad optional, limited radioterapy in advanced Hodgkin lymphoma
2005 P. Gobbi, C. Broglia, F. Valentino, A. Levis, M. Federico, T. Chisei, E. Iannitto, E. Pavone, M. Brugiatelli, L. Baldini
11Q13 polisomy and absence of IGH translocations and chromosome 13Q14 deletion characterize a distinct subgroup of multiple myeloma patients expressing CCND
2005 S. Fabris, D. Intini, L. Agnelli, M. Mattioli, S. Bicciato, D. Verdelli, L. Rossini, L. Baldini, F. Morabito, V. Callea, G. Lambertenghi Deliliers, A. Zanella, L. Lombardi, A. Neri
15-deoxy-D12,14-prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade.
2002 S. Eligini, C. Banfi, M. Camera, S.S. Barbieri, E. Tremoli, S. Colli
2'-O-methoxyethyl splice-switching oligos correct splicing from IVS2-745 β-thalassemia patient cells restoring HbA production and chain rebalance
2021 A. Dong, V. Ghiaccio, I. Motta, S. Guo, R. Peralta, S.M. Freier, A. Watt, S. Damle, Y. Ikawa, D. Jarocha, M. Chappell, C. Stephanou, P. Delbini, C. Chen, S. Christou, M. Kleanthous, K. Smith-Whitley, D. Manwani, C. Casu, O. Abdulmalik, M.D. Cappellini, S. Rivella, L. Breda
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde
2021 P. Musto, M. Engelhardt, J. Caers, N. Bolli, M. Kaiser, N. Van de Donk, E. Terpos, A. Broijl, C.F. De Larrea, F. Gay, H. Goldschmidt, R. Hajek, A.J. Vangsted, E. Zamagni, S. Zweegman, M. Cavo, M. Dimopoulos, H. Einsele, H. Ludwig, G. Barosi, M. Boccadoro, M. Mateos, P. Sonneveld, J.S. Miguel
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
2020 E. Derenzini, S. Mazzara, F. Melle, G. Motta, M. Fabbri, R. Bruna, C. Agostinelli, A. Cesano, C.A. Corsini, N. Chen, S. Righi, E. Sabattini, A. Chiappella, A. Calleri, S. Fiori, V. Tabanelli, A. Cabras, G. Pruneri, U. Vitolo, A.M. Gianni, A. Rambaldi, P. Corradini, P.L. Zinzani, C. Tarella, S. Pileri
5-azacytidine, valproic acid and all-trans retinoic acid in int-2/high risk myelodysplastic syndromes : first results of the gimema MDS 0205 multicenter trial
2008 M.T. Voso, V. Santini V, C. Finelli, L. Borin, E. Angelucci, G. Fioritoni, B. Neri, A. Cortelezzi, O. Villani, G. Zini, M.C. Petti, G. Martinelli, P. Fazi, A. Piciocchi, M. Gobbi, R. Foa, S. Amadori, V. Liso, G. Leone
A guide to oral anticoagulant treatment. Recommendations of the Italian federation of anticoagulation clinics (FCSA)
2003 D. Prisco, D. Barcellona, F. Baudo, M. Berrettini, N. Ciavarella, B. Cosmi, A.G. Dettori, G. Finazzi, C. Manotti, F. Marongiu, M. Moia, G. Palareti, V. Pengo, D. Poli, S. Testa, A. Tosetto, A. Tripodi
A novel G-to-A mutation in intron-N of the protein S gene leading to abnormal RNA splicing in a patient with protein S deficiency
2003 G. D'Andrea, P. Di Perna, V. Brancaccio, E. Faioni, G. Castaman, G. Cibelli, G. Di Minno, M. Margaglione
A patient-adapted pilot study of lenalidomide in combination with low dose dexamethasone (LD) as initial therapy for a primary plasma cell leukemia (PPCL)
2011 P. Musto, M.T. Petrucci, T. Caravita, F. Di Raimondo, A. Falcone, F. Morabito, V. Callea, M. Offidani, F. Gay, N. Filardi, R. Guariglia, G. Pietrantuono, O. Villani, M.C. Martorelli, G. Mansueto, S. Bringhen, A. Levi, K. Todoerti, A. Neri, P. Omedè, F. D’Auria, M. Cavo, M. Boccadoro, A. Palumbo
A pilot study of low-dose subcutaneous alemtuzumab therapy for patients with hemotherapy-refractory chronic lymphocytic leukemia
2005 A. Cortelezzi, M.C. Pasquini, B. Sarina, G. Bertani, F. Grifoni, M. Colombi, G. Lambertenghi Deliliers
A single-arm multi-center trial of bendamustine given with ofatumumab (BENDOFA) in patients with refractory or relapsed chronic lymphocytic leukemia. GIMEMA CLL0809 PROTOCOL
2012 A. Cortelezzi, A.M. Liberati, M. Sciumè, A. Cuneo, G. Reda, G. Gritti, L. Laurenti, F. Zaja, R. Marasca, A. Chiarenzi, L. Orsucci, S. Storti, R. Murru, N. Cascavilla, M. Gobbi, F. Mauro, A. Gregorini, F. Morabito, S. Fabris, F. Maura, A. Piciocchi, M. Vignetti, A. Neri, D. Rossi, G. Gaidano, M. Marinelli, A. Guarini, R. Foà
A very rare simultaneous presence of a ring chromosome 13 and a splicing site mutation on Factor X gene
2013 M. Menegatti, D. Balestra, B. Fabrizzi, R. Asselta, M. Pinotti, F. Peyvandi
ABDV vs Coppebvcad vs Beacopp for the initial treatment of patients with advanced hodgkin lymphoma (HL). Preliminary results of HD2000 GISL trial
2007 M. Federico, S. Luminari, M. Dell’Olio, F. Merli, M. Brugiatelli, C. Mammi, M. Musso, L. Baldini, L. Marcheselli, P.G. Gobbi
Abnormal immunoglobulin serum free light chains (SFLC) are associated with cellular and molecular markers and predict therapy requirements (TFS) in patients with chronic lymphocytic leukemia
2010 F. Morabito, S. Cavalcanti, R. De Filippi, M. Gentile, G. Iaccarino, I. Attolico, G. Cutrona, A. Neri, M. Ferrarini, B. Amoroso, S. Molica, L. Laurenti, G. Del Poeta, A. Pinto
Abnormal immunoglobulin serum free light chains (SFLC) ratio is associated with unfavorable prognostic markers and is a predictor of treatment free survival (TFS) in chronic lymphocytic leukemia
2010 F. Morabito, R. De Filippi, M. Gentile, G. Iaccarino, I. Attolico, G. Cutrona, A. Neri, M. Ferrarini, B. Amoroso, S. Molica, G. Del Poeta, A. Pinto
Abnormal large platelets are associated not only with von Willebrand Disease (VWD) type 2b but also with severe type 3 : the role of von Willebrand Factor (VWF) defects in the impaired megakaryocytopoiesis
2008 M. Punzo, S. La Marca, V. Rubini, G. Cozzi, M.T. Canciani, L. Baronciani, P. Nurden, A.T. Nurden, A.B. Federici
Abnormal neutrophil chemotaxis in bone marrow transplant patients correlates with impaired 31D8 monoclonal antibody binding.
1995 F. Capsoni, F. Minonzio, V. Carbonelli, A.M. Ongari, M.C. Mocellin, D. Soligo, C. Annaloro, A. Della Volpe, G. Lambertenghi Deliliers
Acquired thrombotic thrombocytopenic purpura in a child: Rituximab to prevent relapse. A pediatric report and literature review
2018 S. Mariani, S.M. Trisolini, S. Capria, M.L. Moleti, M. Chisini, G. Ferrazza, M.S. Bafti, M.A. Limongiello, E. Miulli, F. Peyvandi, R. Foà, A.M. Testi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile